Harmine-mediated Reduction of Bone Cancer Pain in Rats Correlates With Suppressed DYRK1A/NF-κB Signaling Axis
Journal of Integrative Neuroscience · 23.06.2025 · 24 (6)
DOI: 10.31083/jin38100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 23.06.2025. Verfasst von Shuyao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Medicine, Zhejiang Sci-Tech University, 310018 Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Harmine, Bone Neoplasms, Cancer Pain, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China, People's Livelihood Science and Technology Innovation Research Project of Jiaxing City.
Abstract (Originalsprache)
Background
Bone cancer pain (BCP) is a prevalent chronic pain condition and a common clinical symptom in patients with advanced cancer. It significantly affects the mobility and quality of life of patients; however, current treatments offer limited efficacy. Harmine, a beta-carboline alkaloid extracted from Peganum harmala, exhibits anti-inflammatory, anxiolytic, analgesic, and neuroprotective properties. However, its antinociceptive properties and mechanisms in BCP models remain unclear. This study aimed to systematically investigate the analgesic effects of Harmine in rats with BCP and explore its underlying molecular mechanisms.
Methods
Using databases such as SwissTargetPrediction and Polypharmacology Browser, molecular docking analysis, behavioral tests, and biochemical analysis, we comprehensively evaluated the effects of Harmine in the BCP model.
Results
The results demonstrated that Harmine significantly alleviated BCP induced by Luciferin-Malignant Atypical Discrete Breast 106 cells (LUC-MADB106) in a dose-dependent manner. Intrathecal administration of Harmine significantly inhibited the upregulation of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) expression and the activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway in the spinal cord dorsal horn (SCDH) of rats with bone cancer.
Conclusions
These findings suggest that Harmine has significant therapeutic potential for alleviating BCP hyperalgesia, providing a foundation for the future development of new drugs targeting BCP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, 310018 Hangzhou, Zhejiang, China.
- Department of Anesthesiology and Pain Research Center, Jiaxing University Affiliated Hospital, The First Hospital of Jiaxing, 314001 Jiaxing, Zhejiang, China.
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
- People's Livelihood Science and Technology Innovation Research Project of Jiaxing City
- Clinical Key Specialties of Zhejiang Province -Anesthesiology
- National Clinical Key Specialties-Oncology
- People’s Livelihood Science and Technology Innovation Research Project of Jiaxing City
Zitieren
APA
Zhang, S., Zheng, S., Jin, J., Li, Y., Chen, L., Lin, J., Yao, M., & Xu, L. (2025). Harmine-mediated Reduction of Bone Cancer Pain in Rats Correlates With Suppressed DYRK1A/NF-κB Signaling Axis. Journal of Integrative Neuroscience, 24(6). https://doi.org/10.31083/jin38100
Vancouver
Zhang S, Zheng S, Jin J, Li Y, Chen L, Lin J, et al. Harmine-mediated Reduction of Bone Cancer Pain in Rats Correlates With Suppressed DYRK1A/NF-κB Signaling Axis. Journal of Integrative Neuroscience. 2025;24(6). doi:10.31083/jin38100
BibTeX
@article{Zhang2025,
author = {Zhang, Shuyao and Zheng, Shang and Jin, Jia and Li, Yuhua and Chen, Liping and Lin, Junjie and Yao, Ming and Xu, Longsheng},
title = {Harmine-mediated Reduction of Bone Cancer Pain in Rats Correlates With Suppressed DYRK1A/NF-κB Signaling Axis},
journal = {Journal of Integrative Neuroscience},
year = {2025},
volume = {24},
number = {6},
doi = {10.31083/jin38100}
}
EUVIMED